![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Burning Rock Gets CE Mark for Its OverC Multi-Cancer Detection Blood Test Kit
Burning Rock Gets CE Mark for Its OverC Multi-Cancer Detection Blood Test Kit
Shanghai, China-based Burning Rock Biotech has received a CE mark for its OverC multi-cancer detection blood test, which is manufactured in both U.S. and Chinese facilities.
The in vitro diagnostic test, which detects trace amounts of tumor-derived DNA methylation markers, can accurately detect and localize multiple cancer types in adults of either sex, aged 40 to 75.
The OverC test is based on Burning Rock's multi-cancer early detection technology ELSA-seq, which combines epigenetics, next-generation sequencing and machine learning.
Upcoming Events
-
11Jul
-
18Jul
-
21Oct